Effective antibiotics are essential for modern medicine that are under threat due to the development of Antimicrobial Resistance (AMR). New therapeutic and diagnostic innovation in antibiotic stewardship is needed to fight AMR and keep treatments effective. However, the current pipeline of these innovations is not sufficient to meet this urgent need.
To improve this, INCATE (INCubator for Antibacterial Therapies in Europe) is bringing together leading academic institutions, industry partners, experienced entrepreneurs and investors. As a unique, not-for-profit public–private partnership INCATE's mission is to support the development of novel antibacterial therapies and preventative interventions, by supporting early-stage innovators in the field of AMR.
In this HealthTech Lecture, INCATE will present its approach and discuss topics such as:
- Chances and risks of publicly funded research institutions and SME
- Development of new antibiotics and possible support by incubators
- The role of incubators for development and marketability of AMR diagnostics innovations
- Necessary political frameworks
- Pull incentives to combat AMR
- Structural hurdles in the German healthcare system
Don't miss the chance to attend this HealthTech-Lecture. The free event will take place via video conference in English. You will receive the relevant dial-in details after registering.